Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model.

Alexandru GaraimanKlaus SteigmillerCatherine GebhardCarina MihaiRucsandra DobrotaCosimo BruniMarco Matucci-CerinicJoerg HenesJeska de Vries-BouwstraVanessa SmithAndrea DoriaYannick AllanoreLorenzo DagnaBranimir AnićCarlomaurizio MontecuccoOtylia Kowal-BieleckaMickael MartinYoshiya TanakaAnna-Maria Hoffmann-VoldUlrike HeldOliver DistlerMike Oliver Beckernull null

Published in: Rheumatology (Oxford, England) (2022)

The DU-VASC model, with good calibration and discrimination ability, revealed that PIs treatment was the most important therapy-related predictor associated with reduced DUs occurrence.

Keyphrases

systemic sclerosis
interstitial lung disease
atrial fibrillation
risk assessment
stem cells
single cell
combination therapy
cell therapy
replacement therapy
smoking cessation